LGALS9 and B-cell chronic lymphocytic leukemia: Applying this approach, we found that galectin-9 levels in CLL patients were considerably higher than that in healthy controls and increased with the progression of the Rai/Binet stage, and high-risk patients which was consistent with the findings of previous studies [12, 13].